The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 08, 2022

Filed:

Mar. 09, 2021
Applicant:

Metabolomycs, Inc, Long Beach, CA (US);

Inventors:

Andre Lopes Carvalho, Barretos, BR;

Rene Aloisio Da Costa Vieira, Barretos, BR;

Ismael Dale Cotrim Guerreiro Da Silva, Sao Paulo, BR;

Edson Guimaraes Lo Turco, Sao Paulo, BR;

Therese Koal, Innsbruck, AT;

Assignee:

Metabolomycs, Inc, Long Beach, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); G01N 33/68 (2006.01); G01N 33/92 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57415 (2013.01); A61B 5/41 (2013.01); G01N 33/57484 (2013.01); A61B 5/00 (2013.01); G01N 33/6812 (2013.01); G01N 33/92 (2013.01); G01N 2333/71 (2013.01); G01N 2333/90 (2013.01); G01N 2570/00 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01); Y10T 436/24 (2015.01);
Abstract

The present invention relates to a metabolic biomarker set for use in assessing breast cancer in a mammalian subject. In particular, the invention relates to a metabolic biomarker set for screening and/or diagnosing breast cancer, the metabolic biomarker set including at least (a) one amino acid selected from glutamine, glutamate and serine, and one lipid, or (b) glutamine and glutamate. Further, the invention relates to a metabolic biomarker set for prediction of therapeutic response to breast cancer neoadjuvant chemotherapy. Moreover, the present invention relates to a method for assessing breast cancer, which includes obtaining a biological sample, preferably blood, from a mammalian subject and measuring in the biological sample the amount and/or ratios of metabolites. By employing the specific biomarkers and the method according to the present invention it becomes possible to more properly and reliably assess breast cancer.


Find Patent Forward Citations

Loading…